Cargando…
SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic: Conclusions for crisis response at a high-volume oncology center
BACKGROUND: During the second wave of the coronavirus disease 2019 (COVID-19) pandemic Austria suffered one of the highest severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rates worldwide. We report performance parameters of a SARS-CoV‑2 screening program established for cancer outpatien...
Autores principales: | Berger, Julia M., Gansterer, Margaretha, Trutschnig, Wolfgang, Bathke, Arne C., Strassl, Robert, Lamm, Wolfgang, Raderer, Markus, Preusser, Matthias, Berghoff, Anna S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375465/ https://www.ncbi.nlm.nih.gov/pubmed/34410467 http://dx.doi.org/10.1007/s00508-021-01927-7 |
Ejemplares similares
-
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events – a retrospective cohort study
por: Mair, Maximilian J., et al.
Publicado: (2022) -
1692P SARS-CoV-2 RNA testing in cancer patients treated at a Department of Medical Oncology in Vienna, Austria
por: Berghoff, A.S., et al.
Publicado: (2020) -
Enhanced SARS-CoV-2 breakthrough infections in patients with hematologic and solid cancers due to Omicron
por: Mair, Maximilian J., et al.
Publicado: (2022) -
Thirteen-year analyses of medical oncology outpatient day clinic data: a changing field
por: Marhold, Maximilian, et al.
Publicado: (2020) -
First application of a protein-based approach for time since death estimation
por: Pittner, Stefan, et al.
Publicado: (2016)